Return to homepagePandemic Pact

Molecular Clamp Stabilized Spike Vaccine for Rapid Response

  • Funded by National Health and Medical Research Council (NHMRC)
  • Total publications:0 publications

Grant number: GA82108

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2021

  • Known Financial Commitments (USD)

    $1,336,470.78

  • Funder

    National Health and Medical Research Council (NHMRC)

  • Research Location

    Australia

  • Lead Research Institution

    University of Queensland

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The Molecular Clamp platform is Australia's most advanced COVID-19 vaccine program. The strategic partners leading this program are aiming to validate safety and efficacy to support development and scale-up of the vaccine for further clinical and potential emergency distribution. The proposed work will identify correlates of protection from infected patients and compare with immune responses elicited by the candidate vaccine. This information will support vaccine dose and adjuvant selection.